# US 2012/0253211 A1 · Systems and methods for varying blood flow to identify autoregulatory ranges in a patient

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253211 A1
- Document ID: US20120253211A1
- Status: Published application
- Kind: A1
- Application number: 13/433,348
- Filed: 2012-03-29
- Published: 2012-10-04
- Earliest claimed: 2011-04-01
- Assignees: Raba Equity Partners II, LLC
- Inventors: Ken M. Brady; Robert A. Baruch
- Web page: https://patentgrep.com/patent/US20120253211A1

## CPC

- A61B 5/02028: {Determining haemodynamic parameters not otherwise provided for, e.g. cardiac contractility or left ventricular ejection fraction}
- A61B 5/031: {Intracranial pressure}
- A61B 5/14553: {specially adapted for cerebral tissue}
- A61M 1/3666: {Cardiac or cardiopulmonary bypass, e.g. heart-lung machines}
- A61M 1/3667: {with assisted venous return}
- A61M 60/109: incorporated within extracorporeal blood circuits or systems
- A61M 60/31: for enhancement of in vivo organ perfusion, e.g. retroperfusion
- A61M 60/523: using blood flow data, e.g. from blood flow transducers
- A61M 60/531: using blood pressure data, e.g. from blood pressure sensors
- A61M 60/562: for making blood flow pulsatile in blood pumps that do not intrinsically create pulsatile flow
- A61M 60/585: User interfaces
- A61B 5/021: Measuring pressure in heart or blood vessels
- A61B 5/026: Measuring blood flow {(A61B3/1233, A61B3/1241 take precedence)}
- A61M 2205/33: Controlling, regulating or measuring
- A61M 2205/3303: Using a biosensor
- A61M 2205/3334: Measuring or controlling the flow rate
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A method may include controlling a bypass pump to introduce blood flow variations to a patient. The method may also include analyzing blood volume in the brain of the patient with respect to the blood flow variations and determining, based on the analyzing, whether an autoregulatory mechanism associated with the brain is operating properly.

## Claims

### Claim 1

A method, comprising:
controlling a bypass pump to introduce blood flow variations to a patient;
analyzing blood volume in the brain of the patient with respect to the blood flow variations; and
determining, based on the analyzing, whether an autoregulatory mechanism associated with the brain is operating properly.

### Claim 2 (depends on 1)

The method of claim 1, wherein the analyzing is performed in the frequency domain.

### Claim 3 (depends on 2)

The method of claim 2, wherein the determining comprises:
determining whether peak blood volume in the brain, measured at a frequency corresponding to an input frequency of the blood flow variations, is phase shifted with respect to the peak blood volume provided by the bypass pump.

### Claim 4 (depends on 1)

The method of claim 1, further comprising:
setting a flow rate of the bypass pump based on the determining.

### Claim 5 (depends on 1)

The method of claim 1, wherein the bypass pump blood flow variations are of fixed amplitude and duration and create a sinusoidally varying slow wave.

### Claim 6 (depends on 5)

The method of claim 5, wherein a frequency of input associated with the blood flow variations is set to a value ranging from 0.05 hertz (Hz) to about 0.2 Hz.

### Claim 7 (depends on 1)

The method of claim 1, wherein the bypass pump blood flow variations create a parametrically varying slow wave.

### Claim 8

A system, comprising:
a pump controller configured to control a bypass pump to introduce blood flow variations to a patient corresponding to an input wave having a first frequency; and
at least one monitoring device configured to:
analyze blood volume in the brain of the patient with respect to the blood flow variations, and
determine, based on the analyzed blood volume, whether an autoregulatory mechanism associated with the brain is operating properly.

### Claim 9 (depends on 8)

The system of claim 8, wherein the at least one monitoring device is further configured to:
determine whether peak blood volume in the brain, measured at the first frequency, is phase shifted with respect to the peak blood flow or pressure provided by the bypass pump, and
determine that the autoregulatory mechanism is working properly, in response to determining that the peak blood volume, measured at the first frequency, is phase shifted with respect to the peak blood flow or pressure provided by the bypass pump.

### Claim 10 (depends on 8)

The system of claim 8, wherein the pump controller is further configured to:
set a flow rate of the bypass pump based on information provided by the at least one monitoring device.

### Claim 11 (depends on 8)

The system of claim 8, wherein the pump controller is configured to:
automatically set a flow rate or pressure of the bypass pump based on information provided by the at least one monitoring device.

### Claim 12 (depends on 8)

The system of claim 8, wherein the first frequency is set to a value ranging from 0.05 hertz (Hz) to about 0.2 Hz.

### Claim 13 (depends on 8)

The system of claim 8, wherein the pump controller is configured to introduce blood flow variations having a fixed amplitude and duration to generate a sinusoidal input wave.

### Claim 14 (depends on 8)

The system of claim 8, wherein the pump controller is configured to introduce blood flow variations corresponding to a parametric waveform.

### Claim 15

A non-transitory computer-readable medium having stored thereon sequences of instructions which, when executed by at least one processor, cause the at least one processor to:
control a bypass pump to introduce blood flow variations to a patient;
analyze blood volume in the brain of the patient with respect to the blood flow variations; and
determine whether an autoregulatory mechanism associated with the brain is functioning properly based on the analyzing.

### Claim 16 (depends on 15)

The non-transitory computer-readable medium of claim 15, wherein when determining whether an autoregulatory mechanism associated with the brain is functioning properly, the instructions cause the at least one processor to:
determine whether peak blood volume in the brain, measured at a first frequency, is negative phase shifted with respect to the peak blood flow rate or pressure provided by the bypass pump, and
determine that the autoregulatory mechanism is working properly, in response to determining that the peak blood volume, measured at the first frequency, is negative phase shifted with respect to the peak blood flow rate or pressure provided by the bypass pump.

### Claim 17 (depends on 15)

The non-transitory computer-readable medium of claim 15, further including instructions for causing the at least one processor to:
automatically adjust the bypass pump to provide a flow rate or pressure in which the autoregulatory mechanism is working properly.

### Claim 18 (depends on 15)

The non-transitory computer-readable medium of claim 15, wherein when controlling the bypass pump, the instructions cause the at least one processor to:
introduce blood flow variations to produce an input wave in the patient's brain.

### Claim 19 (depends on 18)

The non-transitory computer-readable medium of claim 18, wherein when controlling the bypass pump, the instructions cause the at least one processor to generate the input wave having a frequency ranging from 0.05 hertz (Hz) to about 0.2 Hz.

### Claim 20 (depends on 18)

The non-transitory computer-readable medium of claim 18, wherein when analyzing the blood volume in the brain, the instructions cause the at least one processor to:
analyze the blood volume at a frequency corresponding to the frequency of the input wave.
